Search
Menu
Home
HTB
2005
July
July 2005
Contents
Editorial
Volume 6 Number 7 July 2005
Conference reports
14th International HIV Drug Resistance Workshop (14th IHDRW), 7-11 June 2005, Quebec City, Canada
Genetic factors affecting HIV infection and progression rates: immunological factors relating to entry inhibitors
Resistance during MTCT strategies: new data on protective benefit of Combivir added to single-dose nevirapine, and impact of treatment and breastfeeding on the infant
Reduced replicative capacity of M184V explains benefit of 3TC monotherapy compared to stopping all drugs
Interaction between tenofovir and ddI in triple-nucleoside combinations: role of M184V in explaining resistance on failure
Predicting clinical responses to ddI from genotypic resistance
Under-detection of transmission of transmitted resistance and impact on treatment response
Risk of death in UK after diagnosis of 3-class resistance
Antiretrovirals
TMC-114 to be submitted for registration based on Phase 2b trial results: expanded access expected in UK in Autumn 2005
Tipranavir (Aptivus) approved in US
FDA fast track designation for CCR5 inhibitor vicriviroc (SCH-D)
Pfizer discontinues development of capravirine
Treatment access
Six Indian generic ARVs are given FDA tentative approval
Methadone and buprenorphine added to WHO list of essential medicines
MSF’s pricing guide to purchasing ARVs: 8th edition online
WHO 3 by 5 progress report
Pregnancy
Use of T-20 in pregnancy: case study shows transmission occurred in highly treatment experienced mother with multiple-drug resistance
Further reading on nevirapine resistance
Vaccines and microbicides
Human Papilloma Virus vaccines a review of advances in the development of HPV vaccines
Other news
CDC estimate over 1 million HIV-positive people in US
Newly diagnosed HIV infection – review in UK and Ireland
Re-emergence of syphilis in the UK: the new epidemic phases
Prescription of heroin is less costly for society
On the web
Medscape full text articles
HIV inSite Knowledge Base
PDFs
Volume 6 Number 7 July 2005 PDF
HTB RSS
Early access
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news
4 May 2025
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Reduced dosing: a possible crisis response to ART stockouts and closed clinics
5 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate